Published: May 14, 2026
Written by Klarity Editorial Team
Published: May 14, 2026

If you’re a psychiatrist or PMHNP watching the GLP-1 revolution unfold, you’ve probably asked yourself: ‘Can I prescribe these? Should I?’
The short answer: Yes, you can — with the right training, state compliance, and clinical justification. But the longer answer involves navigating scope-of-practice debates, state prescribing rules, telehealth restrictions, and a rapidly shifting reimbursement landscape.
This isn’t about jumping on a trend. It’s about recognizing that many of your patients struggle with obesity — often medication-induced, often intertwined with their mental health — and GLP-1 agonists (semaglutide, tirzepatide, liraglutide) represent a powerful tool you might be uniquely positioned to offer.
Let’s cut through the confusion and get to what matters: the regulations, the business case, and how platforms like Klarity Health can handle the operational complexity so you can focus on patient care.
Many psychiatric patients face a weight problem you helped create. Antipsychotics, mood stabilizers, even some antidepressants cause significant weight gain. A patient stable on olanzapine might gain 30+ pounds — increasing diabetes risk, worsening self-esteem, and potentially destabilizing their mental health.
Psychiatrists already monitor metabolic panels. You’re checking glucose and lipids because you have to. So why not treat the metabolic issue directly?
Dr. Elliott Lewis, a psychiatrist board-certified in obesity medicine, frames it this way: ‘If we truly understand that metabolic and mental health systems are inseparable, then psychiatrists being involved in metabolic treatment makes complete sense.’ He’s not alone — a growing number of psychiatrists are obtaining obesity medicine certification (through ABOM) to formalize their expertise.
Early research suggests GLP-1 medications may help with:
A 2025 meta-analysis in JAMA Psychiatry found no increase in depression or suicidality with GLP-1s versus placebo — in fact, treated groups showed slightly lower depressive symptom rates. The FDA and EMA reviewed safety signals and found no causal link to psychiatric harm.
For psychiatrists worried about destabilizing patients, the evidence is reassuring: with proper monitoring, adding a GLP-1 to someone’s regimen is unlikely to worsen mental health and may improve it.
As a physician, you can prescribe any FDA-approved medication within your competence. GLP-1s fall under that umbrella. Your DEA license covers controlled substances like phentermine (Schedule IV), and your medical license covers legend drugs like semaglutide.
But ‘can you legally’ is different from ‘should you.’ Some states impose specific obesity treatment protocols that apply to all prescribers:
Florida requires:
BMI ≥30 (or ≥27 with comorbidity) documented before prescribing
A comprehensive physical exam (can be telehealth, but must be thorough)
Written informed consent
Follow-up every 3 months minimum for patients on weight-loss meds
Providing the state’s ‘Weight-Loss Consumer Bill of Rights’
New Jersey mandates:
Complete history, physical, labs
Assessment and stabilization of any psychiatric conditions before or alongside weight treatment
Nutritional counseling, exercise, and behavior modification (not just pills)
Virginia requires:
Initial follow-up within 30 days of starting medication
Documentation of a diet/exercise plan
If you’re prescribing via telehealth, you must meet these state standards. That might mean ordering labs remotely, coordinating with a patient’s PCP for vitals, or scheduling monthly check-ins instead of quarterly.
Practical takeaway: You have the authority, but you need protocols in place. Platforms like Klarity handle compliance infrastructure — PDMP checks, structured follow-up schedules, documentation templates — so you’re not reinventing the wheel for each state.
Nurse practitioners face a patchwork of rules:
In states like Washington, Colorado, Montana, New Mexico, experienced PMHNPs can prescribe GLP-1s independently — no physician sign-off required.
But even here, insurers and pharmacies sometimes push back on expensive prescriptions without MD involvement. Some payers require a physician’s name on prior authorizations for GLP-1s, even in FPA states. It’s not a legal requirement, but it’s a business reality.
In Texas, Florida, Pennsylvania, Alabama, you must have a collaborating physician to prescribe:
Texas: Written Prescriptive Authority Agreement required. One physician can supervise up to 7 NPs. Monthly chart reviews and face-to-face meetings mandated.
Florida: Protocol agreement with a supervising physician required for all PMHNPs. Even ‘autonomous’ NPs (limited to family/adult primary care) cannot prescribe controlled substances independently. A Florida PMHNP will always need physician oversight for weight-loss prescribing.
New York: Needs collaboration initially, but after 3,600 hours of practice (~2 years), NPs can practice independently. Most experienced NY PMHNPs work solo.
Illinois: Partial FPA — after ≥4,000 hours and ≥250 CE hours, you can apply for full authority. Illinois also reimburses NPs at 100% of physician rates for Medicaid (a big financial incentive).
California: Transitioning to independence via AB 890. By 2026, certified ‘104’ NPs can open independent practices. But California’s Corporate Practice of Medicine law still requires physician ownership/oversight of medical entities, even if the NP prescribes independently.
What this means for you: If you’re an NP in a restricted state, you’ll need a collaborating MD. That’s an added cost (typically $2,000–5,000/month for a medical director relationship). But if you join a platform like Klarity, that cost is absorbed by the platform — they handle physician oversight, credentialing, and state compliance across all 50 states.
Can a psychiatric NP prescribe for weight loss, or is that outside your training?
Legally, scope is defined by competence, not specialty title. If you gain expertise (through CME, certification, or mentorship), you can expand your scope. Many PMHNPs argue that managing obesity in psych patients (especially med-induced weight gain) is a natural extension of holistic care.
That said, some state boards expect NPs to practice within their population focus. A PMHNP running a standalone weight-loss clinic for the general public might raise eyebrows unless you have additional obesity medicine training. Safer approach: Prescribe GLP-1s as part of integrated care for your existing psychiatric patients.
The DEA extended COVID-era telehealth flexibilities through December 31, 2025, allowing controlled substance prescriptions via telehealth without an initial in-person exam. This includes phentermine (Schedule IV), commonly used for weight loss.
But federal waivers don’t override state law.
About 8 states have stricter telemedicine rules than federal law:
Florida law prohibits telehealth prescriptions of controlled substances except for:
Weight loss isn’t listed. That means you cannot prescribe phentermine via telehealth to Florida patients under state law, even though federal DEA rules allow it.
Workaround: Prescribe non-controlled GLP-1s (semaglutide, tirzepatide) via telehealth — those are allowed. Or have the patient do one in-person visit with a Florida provider to satisfy the controlled-substance exam requirement.
These states require an initial in-person physical exam before prescribing any controlled substance, regardless of federal waivers. If you’re serving patients in these states, you’ll need to coordinate a local exam or limit prescribing to non-controlled options.
In August 2023, Mississippi’s medical board prohibited prescribing GLP-1s off-label solely for weight loss (e.g., using Ozempic instead of Wegovy). You must use the FDA-approved obesity version or face discipline.
Bottom line: Multi-state telehealth for weight management requires state-by-state compliance. Solo practitioners trying to do this themselves will drown in legal research. Platforms like Klarity maintain compliance teams that monitor all 50 states and adjust protocols in real-time.
Medicare Coverage (2026+): In November 2025, the federal government announced Medicare will begin covering anti-obesity medications like Wegovy and Mounjaro. This is a game-changer — millions of seniors will now have coverage for GLP-1s.
Private Insurance: Most commercial plans now cover GLP-1s with prior authorization. You’ll need to document:
Some insurers (like BCBS Texas) impose 30-day supply limits initially to monitor adherence before approving refills.
Medicaid: Coverage varies by state, but expanding. Illinois Medicaid, for example, covers GLP-1s and reimburses NPs at 100% of physician rates.
For medication management visits, you bill standard E/M codes:
Psychiatrists get reimbursed at 100% of physician fee schedules. PMHNPs typically get 85% of physician rates for Medicare/most private payers (though some states like Illinois pay 100%).
Telehealth parity laws in California, New York, Illinois, Pennsylvania require insurers to reimburse telehealth visits at the same rate as in-person. Medicare has extended telehealth reimbursement parity through at least 2025.
If you’re seeing 4 patients per hour for follow-ups (15-min check-ins), that’s ~$300–$400/hour in revenue. Add in initial evals and prior authorizations, and weight management can be a solid service line — especially as more payers cover the medications.
Here’s where most providers get stuck: How do I find these patients?
DIY Marketing (SEO, Google Ads, directories) sounds appealing until you run the numbers:
Google Ads for ‘weight loss doctor near me’ or ‘GLP-1 prescription’ cost $15–40 per click. Conversion rates are 2-5%, meaning you might spend $200–400 per booked patient (and some will no-show).
SEO takes 6-12 months of consistent content, backlinks, and technical optimization before you rank. You’re looking at $2,000–5,000/month in agency fees, plus your time managing it.
Directories (Psychology Today, Zocdoc): Monthly fees ($30–$200/month) plus per-booking charges ($35–100 on Zocdoc). You’re also competing with hundreds of other providers on the same page.
Total cost to acquire one qualified psychiatric patient through DIY channels: $200–500+ when you factor in all costs, failed campaigns, no-shows from cold leads, and the months of investment before results.
Klarity’s Model: Pay-per-appointment. You pay a standard listing fee only when a qualified, pre-matched patient books with you. No upfront ad spend. No monthly subscription. No wasted clicks on tire-kickers.
Instead of gambling $3,000–5,000/month on marketing with uncertain ROI, you pay only when you see patients. That’s guaranteed economics vs. hope-based budgeting.
For providers scaling up or just starting, removing patient acquisition risk entirely is the smart play. You control your schedule, accept only the patients you want, and Klarity handles the rest — credentialing, compliance, telehealth infrastructure, insurance billing (if you want it).
| State | NP Authority | Controlled Substance Telehealth? | Key Weight-Loss Rules |
|---|---|---|---|
| California | Transitioning to FPA (full by 2026); currently needs physician protocols | Yes (federal waiver) | CPOM requires MD ownership; NPs gaining independence but must work within physician entities |
| Texas | Restricted — must have Prescriptive Authority Agreement with MD | Yes, but strict delegation required | Monthly MD/NP meetings; chart reviews; CPM law enforced |
| Florida | Restricted — protocol with MD required; no FPA for PMHNPs | No — state law prohibits CS via telehealth for weight loss | BMI criteria, 3-month follow-ups, informed consent, clinic license required |
| New York | Reduced — independent after 3,600 hours | Yes (federal waiver applies) | No special obesity rules; PMP check required for controlled Rx |
| Pennsylvania | Restricted — collaboration agreement required | Yes (federal waiver) | No additional state obesity protocols; MD name on prescriptions |
| Illinois | Partial FPA — independent after 4,000 hrs + 250 CE hrs | Yes (federal waiver) | 100% Medicaid reimbursement for NPs; no special obesity rules |
Can psychiatrists legally prescribe GLP-1 medications?
Yes. As licensed physicians, psychiatrists can prescribe any FDA-approved medication within their scope. If you’ve gained competency in obesity treatment (through training or certification), prescribing GLP-1s is legally and ethically appropriate — especially for patients whose weight issues intersect with mental health.
Do I need special certification to prescribe weight-loss medications?
No legal requirement, but obesity medicine board certification (ABOM) strengthens your scope and credibility. Many psychiatrists are pursuing this to formalize their expertise in metabolic-psychiatric care.
Can PMHNPs prescribe GLP-1s independently?
In ~26 full-practice-authority states, yes (after meeting experience requirements). In the other ~24 states, you need a collaborating physician. Even in FPA states, some insurers may require MD involvement for high-cost prescriptions.
Can I prescribe phentermine via telehealth?
Federally, yes (through Dec 2025 waivers). But state law varies: Florida prohibits it for weight loss; Alabama requires in-person exam; most other states allow it. Always check state-specific telehealth prescribing rules.
What if a patient has both depression and obesity — can I treat both?
Absolutely. This is where psychiatrists have a unique advantage. You can manage antidepressant therapy and metabolic health in one integrated care plan. Just document that both conditions are being addressed and that weight management is medically necessary (not cosmetic).
Do insurers cover GLP-1s for weight loss?
Increasingly, yes. Medicare will begin coverage in 2026. Most private plans cover with prior authorization (requiring BMI criteria, lifestyle intervention documentation, etc.). Medicaid coverage varies by state but is expanding.
What’s the business case for adding weight management to my practice?
With insurance coverage expanding, patient demand is high. You can bill standard E/M codes ($75–$250 per visit depending on complexity). If you see 4 follow-ups per hour at ~$100 each, that’s $400/hour revenue. The challenge is patient acquisition — which is where a platform like Klarity eliminates the risk by delivering pre-qualified patients on a pay-per-appointment basis.
Here’s the reality: navigating 50 states’ scope-of-practice laws, telehealth restrictions, PDMP requirements, insurance credentialing, and prior authorizations is a full-time job.
Most solo providers attempting multi-state telehealth for weight management either:
Klarity handles all of this:
State compliance: We maintain updated protocols for all 50 states. If Florida changes its telehealth law tomorrow, your workflow adjusts automatically.
Physician oversight: If you’re an NP in a restricted state, we provide collaborating MDs as part of the platform — no separate contracts to negotiate.
Patient flow: Pre-qualified patients already matched to your specialty and availability. No cold calling. No wasted ad spend. Just patients ready to book.
Credentialing & billing: We handle insurance credentialing, prior authorizations, and claims (if you want us to). Or go cash-pay — your choice.
Telehealth infrastructure: HIPAA-compliant video, EHR integration, e-prescribing (including EPCS for controlled substances), automated PDMP checks.
You focus on clinical care. We handle the rest.
Instead of:
You pay per appointment. Only when patients book. That’s it.
If you see 40 patients/month through Klarity, you pay for 40 appointments. If you see 100, you pay for 100. Guaranteed ROI — you only pay when you earn.
If you’re a psychiatrist or PMHNP interested in offering GLP-1 therapy (or any medication management) without the compliance headaches and marketing gamble:
Join Klarity’s provider network →
We’re actively recruiting prescribers in all 50 states. Whether you want to add 10 hours/week of telehealth or build a full practice, Klarity gives you the patients, infrastructure, and peace of mind to grow on your terms.
Questions? Reach out to our provider relations team. We’ll walk you through credentialing, state-specific requirements, and how our pay-per-appointment model works.
The GLP-1 revolution is here. The question isn’t whether psychiatrists should be involved — it’s whether you’re positioned to offer evidence-based, integrated care that treats the whole patient.
With the right training, compliance infrastructure, and patient acquisition model, you can.
Medical Director Co. – ‘How Much Does a Collaborative Physician Cost for Weight Loss, Telehealth, and Medspas? (2025 Definitive Guide)’ (2025) [https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/]
Medical Director Co. – ‘Florida Weight Loss Clinic and Telehealth Compliance Guide (2025)’ (Updated 2025) [https://www.medicaldirectorco.com/florida-weight-loss-clinic-and-telehealth-compliance-guide-2025/]
Medical Director Co. – ‘Texas Weight Loss Clinic & Telehealth Compliance Guide (2025)’ (Updated 2025) [https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/]
Fla. Admin. Code R. 64B15-14.004 – Standards for Prescription of Obesity Drugs (Effective Aug 8, 2022) [https://www.law.cornell.edu/regulations/florida/Fla-Admin-Code-Ann-R-64B15-14-004]
Foley & Lardner LLP (via Mondaq) – ‘A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ (July 24, 2023) [https://www.mondaq.com/unitedstates/healthcare/1447512/a-changing-regulatory-and-reimbursement-landscape-for-weight-loss-drugs]
Find the right provider for your needs — select your state to find expert care near you.